Equillium, Inc. Contracts & Agreements

54 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Warrant
Warrant Agreements
Equillium, Inc.
Biotechnology
NY
2021
Equillium, Inc. 2024 Inducement Plan and Forms of Stock Option Grant Notice, Option Agreement, and Notice of Exercise thereunder
Stock Agreements
Equillium, Inc.
2024
Open Market Sale Agreement, dated as of October 5, 2023, by and between Equillium, Inc. and Jefferies LLC
Equillium, Inc.
2023
Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018)
Collaboration Agreements
Equillium, Inc.
2023
Clinical Supply Agreement, dated May 22, 2017, by and between Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018)
Supply Agreements
Equillium, Inc.
2023
Agreement and Plan of Merger, dated September 6, 2022, by and among Equillium, Inc., Metacrine, Inc., Equillium Acquisition Sub, Inc., and Triumph Merger Sub, Inc
Merger Agreements
Equillium, Inc.
Biotechnology
DE
2022
First Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated December 18, 2020
Loan Agreements
Equillium, Inc.
Biotechnology
2022
Amended and Restated Equillium, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Equillium, Inc.
2022
Third Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated February 14, 2022
Loan Agreements
Equillium, Inc.
2022
Confidential Separation Agreement and General Release of All Claims dated February 13, 2022, by and between Registrant and Dolca Thomas, M.D
Separation Agreements
Equillium, Inc.
Biotechnology
CA
2022
Agreement and Plan of Merger, dated February 14, 2022, by and among the Company, Bioniz, Merger Sub and Kevin Green, solely in his capacity as Securityholders Representative
Merger Agreements
Equillium, Inc.
Biotechnology
DE
2022
Fourth Amendment to Collaboration and License Agreement by and between Registrant and Biocon Limited, dated April 14, 2021
Collaboration Agreements
Equillium, Inc.
2021
Second Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated April 23, 2021
Loan Agreements
Equillium, Inc.
2021
Amended and Restated Offer Letter, effective January 26, 2021, by and between the Registrant and Joel Rothman
Equillium, Inc.
2021
Equillium, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Equillium, Inc.
Biotechnology
2021
Purchase Agreement between the Company and the Purchasers, dated February 3, 2021
Purchase Agreements
Equillium, Inc.
Biotechnology
NY
2021
Offer Letter, dated December 15, 2020, by and between Equillium, Inc. and Dolca Thomas, M.D
Equillium, Inc.
Biotechnology
CA
2020
Second Amendment to Offer Letter, effective as of September 28, 2020, by and between the Company and Krishna Polu
Equillium, Inc.
2020
Underwriting Agreement, dated August 13, 2020, by and among Equillium, Inc. and Jefferies LLC, SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated, acting as the...
Underwriting Agreements
Equillium, Inc.
2020
Equillium, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Equillium, Inc.
2020
Open Market Sale Agreement, dated as of July 14, 2020, by and between Equillium, Inc. and Jefferies LLC
Equillium, Inc.
Biotechnology
NY
2020
Registration Rights Agreement, dated as of March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Equillium, Inc.
Biotechnology
NY
2020
Purchase Agreement, dated as of March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC
Purchase Agreements
Equillium, Inc.
2020
Description of Common Stock
Stock Agreements
Equillium, Inc.
2020
Second Amendment to Collaboration and License Agreement, dated April 22, 2019, by and between the Registrant and Biocon Limited
Collaboration Agreements
Equillium, Inc.
2020
Third Amendment to Collaboration and License Agreement, dated December 10, 2019, by and between the Registrant and Biocon Limited
Collaboration Agreements
Equillium, Inc.
Biotechnology
2020
Offer Letter, dated January 19, 2018, by and between the Registrant and Christine Zedelmayer
Equillium, Inc.
Biotechnology
CA
2020
First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Daniel M. Bradbury
Equillium, Inc.
Biotechnology
CA
2020
First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Krishna Polu
Equillium, Inc.
2020
First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Bruce D. Steel
Equillium, Inc.
2020
First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Christine Zedelmayer
Equillium, Inc.
Biotechnology
CA
2020
Warrant to Purchase Common Stock, dated September 30, 2019, issued to Oxford Valley Finance LLC
Warrant Agreements
Equillium, Inc.
Biotechnology
CA
2019
Warrant to Purchase Common Stock, dated September 30, 2019, issued to Silicon Valley Bank
Warrant Agreements
Equillium, Inc.
2019
Loan and Security Agreement, effective as of September 30, 2019, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank
Loan Agreements
Equillium, Inc.
2019
Equillium, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Equillium, Inc.
Biotechnology
2019
Form of Underwriting Agreement
Underwriting Agreements
Equillium, Inc.
Biotechnology
NY
2018
Form of Common Stock Certificate of the Registrant
Stock Agreements
Equillium, Inc.
Biotechnology
2018
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder
Bonus & Incentive Agreements
Equillium, Inc.
2018
Equillium, Inc. 2018 Employee Stock Purchase Plan
Stock Agreements
Equillium, Inc.
2018
Equillium, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Equillium, Inc.
Biotechnology
2018
First Amendment to Collaboration and License Agreement, effective as of September 28, 2018, by and between the Registrant and Biocon Limited
Collaboration Agreements
Equillium, Inc.
2018
Form of Indemnity Agreement by and between the Registrant and its directors and officers
Equillium, Inc.
2018
Equillium, Inc. 2017 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder
Bonus & Incentive Agreements
Equillium, Inc.
2018
Equillium, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder
Bonus & Incentive Agreements
Equillium, Inc.
Biotechnology
DE
2018
Equillium, Inc. 2018 Employee Stock Purchase Plan
Stock Agreements
Equillium, Inc.
2018
Equillium, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Equillium, Inc.
2018
Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018)
Collaboration Agreements
Equillium, Inc.
Biotechnology
NY
2018
Clinical Supply Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018)
Supply Agreements
Equillium, Inc.
2018
Standard Office Lease, effective as of February 1, 2018, by and between the Registrant and La Jolla Shores Plaza, LLC
Lease Agreements
Equillium, Inc.
2018
Offer Letter, dated June 1, 2018, by and between the Registrant and Daniel M. Bradbury
Equillium, Inc.
Biotechnology
CA
2018
Offer Letter, dated March 19, 2018, by and between the Registrant and Jason A. Keyes
Equillium, Inc.
2018
Offer Letter, dated June 1, 2018, by and between the Registrant and Bruce D. Steel
Equillium, Inc.
Biotechnology
CA
2018
Amended and Restated Offer Letter, dated June 7, 2018, by and between the Registrant and Stephen Connelly, Ph.D
Equillium, Inc.
Biotechnology
CA
2018
Offer Letter, dated August 1, 2018, by and between the Registrant and Krishna Polu, M.D
Equillium, Inc.
2018